Hi Skint,
Good find on a previous drug Dr Stamler had bought to market with impressive results.
$1B price is definately extremely impressive, and thats just for MSA not other potential diseases it may help treat.
Given that the drug has shown positive effects on late stage MSA patients, one could only expect better results, as the drug is removing the excess ferrous iron, therefore reducing oxidative stress on the cell, plus preventing iron aggregation, and restoring natural homeostasis.
Given the current SP following positive results, you wouldnt have expected to go back to lower levels pre release of results.
Positive read of the 201 study will definately move the market, but it will be interesting to see what is planned with the podcast tomorrow, and see what MST financials plans to assist move the company forward.
Hi Skint,Good find on a previous drug Dr Stamler had bought to...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $71.15K | 17.43M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 101 | 87272775 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 24185511 | 15 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |